Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Soft Plaque vs. Calcified Plaque: Which Is Riskier and What Tests Can See

Soft Plaque vs. Calcified Plaque: Which Is Riskier and What Tests Can See

Soft plaque is the fatty, non-calcified part of the buildup inside an artery wall. Calcified plaque is plaque in which calcium has been deposited, which makes it hard and easy to see on a CT scan. They are stages of the same disease, and most people with plaque have both.

Soft, fatty plaque is the type most closely tied to heart attacks, and very dense calcium tends to mark plaque that is more stable. But a high calcium score still means a lot of plaque overall, so neither type can be judged alone.

Key takeaways

  • Soft and calcified plaque are not rival conditions; calcium is laid down in plaque as it ages.
  • Studies using CT angiography link fatty, low-density plaque to future heart attacks more strongly than narrowing or calcium score.
  • For the same amount of calcium, denser calcium has been associated with lower risk, but more calcium still means more risk.
  • A calcium score sees only calcified plaque, so soft plaque in the heart arteries needs a contrast CT to be seen.
  • Intensive cholesterol lowering changes plaque modestly; nobody can promise clean arteries.

Two stages of one process

Plaque begins when cholesterol-carrying particles get trapped in the artery wall and the immune system reacts. Over years this forms a fatty core covered by a fibrous cap. Later, calcium is deposited in older parts of the plaque.

So soft plaque is generally younger and calcified plaque is older, and one artery can hold both. Our guide to how arterial plaque builds up covers the biology step by step. This article looks at how the two types differ in risk and in what tests can show.

FeatureSoft (non-calcified) plaqueCalcified plaque
What it isA fatty core with immune cells under a fibrous capOlder plaque with calcium deposits
Seen on a calcium scoreNoYes
Seen on a CT angiogramYesYes
Link to heart attacksFatty, low-density plaque was the strongest predictor in one large CT studyMore calcium means more risk overall. Denser calcium means less risk for the same amount
With intensive statin treatmentTotal plaque volume shrank slightly in pooled trialsCalcification increased

Which one is riskier?

Most heart attacks start when a plaque tears or wears away at its surface and a clot forms on it. The plaques that do this tend to have a large fatty core and a thin cap. That is the reasoning behind calling soft plaque less stable.

Imaging studies support it. Researchers measured plaque on CT angiograms from 1,769 patients with stable chest pain and followed them for a median of 4.7 years. The amount of low-density, non-calcified plaque was the strongest predictor of a later heart attack, ahead of a clinical risk score, the calcium score and the degree of narrowing.1

Risky plaque also does not have to be causing a blockage. In a study of people who went on to have an acute coronary event, 81% of the plaques with high-risk features narrowed the artery by less than half.2

Is calcium protective? Not quite

It is tempting to conclude that calcified plaque is the safe kind. The evidence says something narrower.

In 3,398 MESA participants who had calcium on a scan, a larger volume of calcium was linked to more cardiovascular events, while denser calcium was linked to fewer events at any given volume.3 A separate CT study found that people who later had an acute coronary event had a similar total volume of calcified plaque to those who did not, but less of the very densest calcium.4

So density looks like a marker of stability. Volume is a marker of how much disease there is. The standard calcium score rises with both, and in practice a high score is still a warning, because people with a lot of calcium usually have plenty of soft plaque too. In the chest pain study above, the amount of low-density plaque tracked closely with the calcium score.

What each test can and cannot see

Calcium score. A coronary calcium scan detects calcified plaque only. A score of zero lowers the odds of significant plaque but does not rule out soft plaque.

CT angiogram. A CT with contrast dye shows both types and how much they narrow the artery. It is a diagnostic test, used mainly for people with symptoms. We compare the two scans in calcium score vs. CT angiogram.

Carotid ultrasound. An ultrasound of the neck arteries, including CIMT, can show plaque there. It is an indirect clue about the heart. US guidance from 2013 does not recommend routine CIMT measurement for predicting a first cardiovascular event.5

Blood tests. ApoB, Lp(a) and hs-CRP do not image plaque of either type. They measure the forces that build it.

What treatment does to each type

Lowering cholesterol particles does not simply dissolve plaque. In a pooled analysis of eight trials that used ultrasound inside the coronary arteries, plaque volume fell slightly with high-intensity statin therapy and grew with low-intensity or no statin therapy. Calcium increased in every group, and more so with statins.6

The authors' reading was that statins may stabilize plaque partly by calcifying it. One practical consequence: a calcium score can rise on treatment without meaning the treatment has failed. Our article for people already on a statin explains how to read a score in that setting.

Keep expectations honest. The changes in plaque volume seen in trials are small, and no test or treatment can promise to clear your arteries. Do not start, stop or change a medication without your prescriber.

Your next step: know what your tests can show

At our clinic, the Enhanced Assessment ($999) includes a coronary calcium score, which measures calcified plaque, and a CIMT ultrasound of the neck arteries. Neither Cardio Res-Q assessment includes a CT angiogram, so soft plaque in the heart arteries is not imaged directly. If that question matters in your case, it is one for a cardiologist.

Both the Enhanced and the Comprehensive Assessment ($775) measure ApoB, Lp(a) and hs-CRP, which describe what is driving plaque of either type. To compare the two options, read Comprehensive vs. Enhanced Assessment or visit the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does a calcium score of zero mean I have no soft plaque?

No. A calcium scan cannot see plaque that has not calcified. A zero makes significant plaque less likely and is reassuring for most people without symptoms, but it is not proof of clean arteries, and it does not explain symptoms.

Does soft plaque turn into calcified plaque?

Often, over years. Calcium is deposited as plaque ages, and trial data suggest statin treatment speeds that calcification. This is one reason calcium scores tend to rise over time, even in people whose risk is being well managed.

Can soft plaque go away?

Trials of intensive cholesterol lowering have shown small reductions in plaque volume, not disappearance. The realistic aims are slower growth, more stable plaque and lower risk. Be cautious of anyone who promises more than that.

Is a high calcium score good news, since calcified plaque is more stable?

No. A high score means a large amount of plaque, and people with more calcium have more cardiovascular events. Density is a finer point within the score. It does not turn a high score into a low-risk result.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Williams MC, et al. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation 2020. PMID 32174130 · doi:10.1161/CIRCULATIONAHA.119.044720↩
  2. Ferraro RA, et al. Non-obstructive high-risk plaques increase the risk of future culprit lesions comparable to obstructive plaques without high-risk features: the ICONIC study. Eur Heart J Cardiovasc Imaging 2020. PMID 32535636 · doi:10.1093/ehjci/jeaa048↩
  3. Criqui MH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014. PMID 24247483 · doi:10.1001/jama.2013.282535↩
  4. van Rosendael AR, et al. Association of High-Density Calcified 1K Plaque With Risk of Acute Coronary Syndrome. JAMA Cardiol 2020. PMID 31968065 · doi:10.1001/jamacardio.2019.5315↩
  5. Goff DC Jr, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014. PMID 24239921 · doi:10.1016/j.jacc.2013.11.005↩
  6. Puri R, et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 2015. PMID 25835438 · doi:10.1016/j.jacc.2015.01.036↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify